Back

Spatial Immunophenotyping from Whole-Slide Multiplexed Tissue Imaging Using Convolutional Neural Networks

Yosofvand, M.; Edmiston, S. N.; Smithy, J. W.; Peng, X.; Kostrzewa, C. E.; Lin, B.; Ehrich, F.; Reiner, A.; Miedema, J.; Moy, A. P.; Orlow, I.; Postow, M. A.; Panageas, K.; Seshan, V. E.; Callahan, M. K.; Thomas, N. E.; Shen, R.

2024-08-19 bioinformatics
10.1101/2024.08.16.608247 bioRxiv
Show abstract

The multiplexed immunofluorescence (mIF) platform enables biomarker discovery through the simultaneous detection of multiple markers on a single tissue slide, offering detailed insights into intratumor heterogeneity and the tumor-immune microenvironment at spatially resolved single cell resolution. However, current mIF image analyses are labor-intensive, requiring specialized pathology expertise which limits their scalability and clinical application. To address this challenge, we developed CellGate, a deep-learning (DL) computational pipeline that provides streamlined, end-to-end whole-slide mIF image analysis including nuclei detection, cell segmentation, cell classification, and combined immuno-phenotyping across stacked images. The model was trained on over 750,000 single cell images from 34 melanomas in a retrospective cohort of patients using whole tissue sections stained for CD3, CD8, CD68, CK-SOX10, PD-1, PD-L1, and FOXP3 with manual gating and extensive pathology review. When tested on new whole mIF slides, the model demonstrated high precision-recall AUC. Further validation on whole-slide mIF images of 9 primary melanomas from an independent cohort confirmed that CellGate can reproduce expert pathology analysis with high accuracy. We show that spatial immuno-phenotyping results using CellGate provide deep insights into the immune cell topography and differences in T cell functional states and interactions with tumor cells in patients with distinct histopathology and clinical characteristics. This pipeline offers a fully automated and parallelizable computing process with substantially improved consistency for cell type classification across images, potentially enabling high throughput whole-slide mIF tissue image analysis for large-scale clinical and research applications.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Laboratory Investigation
13 papers in training set
Top 0.1%
11.1%
2
Scientific Reports
3612 papers in training set
Top 7%
8.0%
3
Scientific Data
209 papers in training set
Top 0.4%
6.8%
4
Nature Communications
5641 papers in training set
Top 23%
6.8%
5
npj Precision Oncology
53 papers in training set
Top 0.1%
6.8%
6
Frontiers in Immunology
638 papers in training set
Top 3%
4.4%
7
Communications Biology
993 papers in training set
Top 3%
4.1%
8
Cancer Research Communications
51 papers in training set
Top 0.3%
3.3%
50% of probability mass above
9
Cytometry Part A
33 papers in training set
Top 0.1%
3.1%
10
PLOS ONE
5266 papers in training set
Top 40%
2.8%
11
Computational and Structural Biotechnology Journal
242 papers in training set
Top 3%
1.7%
12
Small Methods
29 papers in training set
Top 0.2%
1.7%
13
Bioinformatics
1204 papers in training set
Top 7%
1.7%
14
GigaScience
212 papers in training set
Top 2%
1.7%
15
Cell Reports Medicine
153 papers in training set
Top 2%
1.5%
16
Journal of Translational Medicine
57 papers in training set
Top 0.9%
1.5%
17
iScience
1154 papers in training set
Top 22%
1.3%
18
Modern Pathology
22 papers in training set
Top 0.3%
1.1%
19
Briefings in Bioinformatics
354 papers in training set
Top 6%
1.1%
20
BMC Methods
15 papers in training set
Top 0.1%
1.1%
21
Journal of Pathology Informatics
15 papers in training set
Top 0.2%
1.1%
22
Communications Medicine
113 papers in training set
Top 3%
1.1%
23
BMC Medical Genomics
50 papers in training set
Top 1%
1.0%
24
Genome Medicine
183 papers in training set
Top 5%
0.9%
25
npj Systems Biology and Applications
125 papers in training set
Top 2%
0.9%
26
Frontiers in Oncology
103 papers in training set
Top 3%
0.9%
27
Science Advances
1243 papers in training set
Top 30%
0.9%
28
npj Breast Cancer
23 papers in training set
Top 0.5%
0.6%
29
PNAS Nexus
159 papers in training set
Top 4%
0.6%
30
Antibody Therapeutics
16 papers in training set
Top 0.3%
0.6%